adenovirus-based vaccine 腺病毒載體疫苗

adenovirus-based vaccine
繁：腺病毒載體疫苗
简：腺病毒载体疫苗

阿斯利康疫苗使用腺病毒載體技術，EMA認為吉巴氏綜合症有合理可能與腺病毒載體疫苗存在因果關係。

【阿斯利康疫苗】EMA列吉巴氏綜合症為副作用（2021年9月9日）。經濟日報，取自 https://bit.ly/3nmCVKd

Both are adenovirus-based vaccines, as opposed to the mRNA shots offered by Moderna and Pfizer/BioNTech. The J&J and AZ vaccines also have been linked to very rare cases of blood clots that occur alongside bleeding.

AstraZeneca’s COVID-19 shot joins the list of vaccines flagged for rare Guillain-Barre syndrome. (2021, Sep 9). Fierce Pharma. Retrieved from https://www.fiercepharma.com/pharma/astrazeneca-s-covid-19-shot-joins-list-vaccines-flagged-for-rare-guillain-barre-syndrome